Join
Live feed
·
INSIDERFilingvia Quantisnow
Bolt Biotherapeutics Inc. logo

Chief Operating Officer Yonehiro Grant was granted 30,000 shares, increasing direct ownership by 336% to 38,918 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BOLT· Bolt Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BOLT (Bolt Biotherapeutics Inc.) and more on Quantisnow.